J. Michel

Centre Hospitalier Régional de Metz-Thionville — France

Medicine · Health Sciences

18h-index1.2kcitations27works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Research Studies(12), Neuroendocrine Tumor Research Advances(7), Lung Cancer Treatments and Mutations(6), Cancer Treatment and Pharmacology(5), Cancer therapeutics and mechanisms(5)

Publications27 total

Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia
Leukemia & lymphoma/Leukemia and lymphoma·2021· 2 cited
Induction Chemotherapy with Cisplatin, Etoposide and Vindesine before Radiation Therapy for Nonsmall-Cell Lung Cancer
Antibiotics and chemotherapy/Antibiotica et chemotherapia·2015· 28 cited
Autochthonous white rot fungi from the tropical forest: Potential of Cuban strains for dyes and textile industrial effluents decolourisation
AFRICAN JOURNAL OF BIOTECHNOLOGY·2008· 20 citedOpen Access
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics
British Journal of Cancer·2001· 66 citedOpen Access
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party
European Journal of Cancer·1997· 83 cited
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC)
Lung Cancer·1996· 31 cited
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
Journal of Clinical Oncology·1996· 72 cited
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
Journal of Clinical Oncology·1995· 393 cited
Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting
Annals of Oncology·1994· 21 citedOpen Access
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.
Journal of Clinical Oncology·1993· 78 cited
A phase II study evaluating CAVi (cyclophosphamide, adriamycin, vincristine) potentiated or not by amphotericin B entrapped into sonicated liposomes, as salvage therapy for small cell lung cancer
Lung Cancer·1990· 18 cited
Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer
Cancer Chemotherapy and Pharmacology·1990· 8 cited
A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer
Annals of Oncology·1990· 28 citedOpen Access
Cyclophosphamide, doxorubicin and vincristine with amphotericin B in sonicated liposomes as salvage therapy for small cell lung cancer
European Journal of Cancer and Clinical Oncology·1990· 15 cited
Phase II trial of fotemustine in advanced colorectal cancer
European Journal of Cancer and Clinical Oncology·1990· 3 cited
Oral versus intramuscular high-dose medroxyprogesterone acetate (HD-MPA) in advanced breast cancer. A randomized study of the Belgian Society of Medical Oncology.
PubMed·1987· 9 cited
A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.
Journal of Clinical Oncology·1986· 136 cited
[Polychemotherapy of undifferentiated small cell bronchial cancer. Long-term results].
PubMed·1986· 1 cited
Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC lung cancer working party (Belgium)
Cancer·1985· 27 cited
Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
PubMed·1983· 32 cited
page 1 of 2Next →

Frequent Co-authors

Jean‐Paul Sculier(11), Jean Klášterský(11), P Libert(8), G. Bureau(8), G. Vandermoten(8), R Sergysels(7), P. Mommen(7), J Thiriaux(6), O Van Cutsem(6), Y. Kenis(6), G Dabouis(5), P Rocmans(5), D. Becquart(5), Marianne Paesmans(4), P Ravez(4), M.C. Berchier(4), J. Lecomte(4), M Mairesse(3), V. Giner(3), J Schmerber(3)